A recent article detailed the 2012 sales of several highly successful medications.  At the top of the list were two GI drugs:

• Humira     $4,505,380,000
• Remicade $3,796,422,000

Here’s the link:

Gastroenterology & Endoscopy News – Billion–Dollar Savings From